142 related articles for article (PubMed ID: 32744152)
1. p53 Expression in Canine Liposarcoma Correlates With Myxoid Variant and Higher Proliferative Activity.
Avallone G; Muscatello LV; Leoni A; Roccabianca P; Lepri E; Crippa L; Bacci B
Vet Pathol; 2020 Sep; 57(5):620-622. PubMed ID: 32744152
[TBL] [Abstract][Full Text] [Related]
2. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.
Avallone G; Roccabianca P; Crippa L; Lepri E; Brunetti B; Bernardini C; Forni M; Olandese A; Sarli G
Vet Pathol; 2016 Jul; 53(4):773-80. PubMed ID: 26993784
[TBL] [Abstract][Full Text] [Related]
3. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated liposarcoma with lipoma-like well-differentiated liposarcoma: clinicopathological study of 30 cases, with particular attention to the comingling pattern of well- and dedifferentiated components: a proposal for regrouping of the present subclassification of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Iwasa Y; Nakashima Y
Int J Surg Pathol; 2013 Feb; 21(1):15-21. PubMed ID: 22674916
[TBL] [Abstract][Full Text] [Related]
6. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
7. Liposarcoma in children and young adults: a clinicopathologic and molecular study of 23 cases in one of the largest institutions of China.
Peng R; Li N; Lan T; Chen H; Du T; He X; Chen M; Xie Y; Zhang Z; Zhao W; Zhang H
Virchows Arch; 2021 Sep; 479(3):537-549. PubMed ID: 33738541
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
9. Well-differentiated liposarcoma associated with benign lipoma.
Hatano H; Morita T; Ogose A; Hotta T; Kobayashi H; Honma K
Anticancer Res; 2004; 24(2C):1039-44. PubMed ID: 15154619
[TBL] [Abstract][Full Text] [Related]
10. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K
Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification.
Arici A; Ozgur T; Ugras N; Yalcinkaya U
Indian J Cancer; 2013; 50(3):164-9. PubMed ID: 24061453
[TBL] [Abstract][Full Text] [Related]
12. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
13. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine Kinase Receptor Expression in Canine Liposarcoma.
Avallone G; Pellegrino V; Roccabianca P; Lepri E; Crippa L; Beha G; De Tolla L; Sarli G
Vet Pathol; 2017 Mar; 54(2):212-217. PubMed ID: 27698080
[TBL] [Abstract][Full Text] [Related]
15. Update on liposarcoma: a review for cytopathologists.
Dodd LG
Diagn Cytopathol; 2012 Dec; 40(12):1122-31. PubMed ID: 21932353
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma].
Chen C; He X; Jing WY; Qiu Y; Chen M; Luo TY; Liu XY; Chen HJ; Zhang HY; Bu H
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):190-195. PubMed ID: 35249280
[No Abstract] [Full Text] [Related]
17. A novel sclerosing atypical lipomatous tumor/well-differentiated liposarcoma in a 7-year-old girl: report of a case with molecular confirmation.
Peng R; Chen H; Yang X; Zhang X; Zhang Z; He X; Zhang H
Hum Pathol; 2018 Jan; 71():41-46. PubMed ID: 28705709
[TBL] [Abstract][Full Text] [Related]
18. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.
Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL
Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480
[TBL] [Abstract][Full Text] [Related]
19. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
[TBL] [Abstract][Full Text] [Related]
20. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
Boltze C; Schneider-Stock R; Jäger V; Roessner A
Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
